Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Transplantation Proceedings|February 11, 2014
Adenosine triphosphate production by peripheral blood CD4⁺T cells in clinically stable renal transplant recipientsA G Vittoraki, J N Boletis, M N Darema, et al.
Rheumatology (Oxford, England)|February 14, 2004
Lupus nephritis: treatment with mycophenolate mofetilP P Kapitsinou, J N Boletis, F N Skopouli, et al.
Transplantation Proceedings|December 5, 2017
Syndrome of Inappropriate Antidiuretic Hormone Secretion Complicating Systemic Nocardiosis in a Renal Transplant Recipient: A Case ReportC Melexopoulou, I D Pavlopoulou, A Zormpala, et al.
Lupus|July 16, 2008
Kidney transplantation in lupus patients: a case-control study from a single centreS Lionaki, P P Kapitsinou, A Iniotaki, et al.
Clinical Transplants|July 5, 2012
Long-term post transplant alloantibody monitoring: a single center experienceI S Ntokou, J N Boletis, M Apostolaki, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Cholestatic syndromes in renal transplant recipients with HCV infectionJ N Boletis, J K Delladetsima, F Makris, et al.
Transplantation Proceedings|September 8, 2004
Cyclosporine levels at 2 hours after dose and body mass index in relation to graft function in renal transplant patients treated with azathioprine or mycophenolate mofetilI Konstadinidou, N Giapraka, S Lionaki, et al.
Transplantation Proceedings|June 27, 2003
Beneficial effects of fluvastatin on progressive renal allograft dysfunctionI Konstadinidou, J N Boletis, D Perrea, et al.
Arthritis and Rheumatism|February 5, 2005
Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down-regulation of the T cell costimulatory molecule CD40 ligand: an open-label trialP P Sfikakis, J N Boletis, S Lionaki, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 18, 2005
A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipientsI D Pavlopoulou, V Ph Syriopoulou, H Chelioti, et al.
Pageof 3